Key result
GDF-15 shows strong potential as a prognostic biomarker and cardioprotective cytokine across cardiovascular diseases.
Answers are grounded in this paper and cite their sources.
CONTEXT: Growth differentiation factor 15 (GDF-15) is a novel cytokine showing close association with cardiovascular diseases. The biological mechanism and clinical use of GDF-15 in cardiovascular diseases have been well demonstrated. We review recent investigations from both basic research and clinical trials into the biological role of GDF-15. METHODS: The data were obtained mainly from MedLine via PubMed and from our own investigations. RESULTS: Laboratory investigations revealed that GDF-15 has biphasic effects on cellular survival by several signaling pathways. GDF-15 participates in several cardiovascular pathological processes such as cardiac remodeling, ischemia/reperfusion injury and atherosclerotic plaque formation. As well, GDF-15 was found a prognostic biomarker of heart failure and acute coronary syndrome. The evidence for diagnostic or therapeutic utility is poor. CONCLUSION: GDF-15 has great potential as a biomarker in cardiovascular diseases, especially for prognosis, and is seen as a myocardial protective cytokine, but the exact mechanism of GDF-15 in cardiovascular diseases remains unknown.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2011) conducted a review in Cardiovascular diseases. Growth differentiation factor 15 (GDF-15) was evaluated. Growth differentiation factor 15 shows great potential as a prognostic biomarker and myocardial protective cytokine in cardiovascular diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: